Bromfenac Sodium

溴芬酸钠

Report date: 2026/04/22 20:01:10
NME

Base Information

Drug NameBromfenac Sodium
Drug Alias Name溴芬钠酸Natax溴芬酸Nuckonebromfenaco +[24] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsOcular inflammationPainPain, Postoperative +[10] 
Global Approved IndicationsOcular inflammationPain, PostoperativeEye Pain
Approved Indications in ChinaOcular inflammationEye Pain
Original Approved Country/TerritoryN/A
Original Approved Date1997/07/15
Country/TerritoryUnited StatesEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBausch + Lomb Ireland LtdISTA Pharmaceuticals IncBausch And Lomb Inc +[4] 
Inactive CompaniesSun Pharmaceutical Industries LtdJohns Hopkins UniversityBausch & Lomb Incorporated +[4] 
Active IndicationsOcular inflammationPain, PostoperativeInflammation +[4] 
Inactive IndicationsPainPostoperative ComplicationsMacular Edema +[6] 

Other Information

ATC CodeS01BC11
Related LinksWikipediaDrugBankKEGG